China, Nov. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Azacitidine Combined With Venetoclax and ATRA in Newly Diagnosed AML'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136748
Registration Time: 2026/11/15
Type: Interventional study
Primary Sponsor: The First Affiliated Hospital of Soochow University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=327104
Published by HT Digital Content Services with permission from Health Daily Digest....